Delivery Order SPE2DB20D3103-SPE2DB23FP6Z7

Award Date 9/12/23
Potential Completion Date 9/13/23
Potential Value $5.2K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,622.88 firm-fixed-price delivery order is for the pharmaceutical product Trulicity 3 mg/0.5 ml pen with an ultimate completion date of November 9, 2021. This delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, which serves as the primary vehicle for the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $7,476.01 firm-fixed-price delivery order is for the pharmaceutical product Trulicity 0.75 mg/0.5 ml pen. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies to support military...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $14,931.68 firm fixed-price delivery order is for the pharmaceutical product Trulicity 3 mg/0.5 ml pen with a completion date of January 16, 2024. The award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Cencora, Inc. holds with the DLA Troop Support Medical. This single-award IDC serves as...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $11,437.02, is for the delivery of Trulicity 1.5 mg/0.5 ml pen 0.5 ml, a prescription medication. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which runs through December 31, 2025. The IDC serves as the primary vehicle for Cencora, Inc....
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was issued by the Defense Logistics Agency (DLA) Troop Support Medical for the delivery of Trulicity 1.5 mg/0.5 ml pen 0.5 ml, a pharmaceutical product. The contract is a delivery order with a firm fixed price of $3,076.26 and an ultimate completion date of April 25, 2023. This award is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support...
This federal contract award, valued at $5,805.60, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of the pharmaceutical product Trulicity 1.5 mg/0.5 ml pen with a completion date of March 15, 2023. This contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $3,918.78 firm fixed-price delivery order is for the pharmaceutical product Trulicity 1.5 mg/0.5 ml pen 0.5 ml. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Cencora, Inc. holds with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $3,643.40 firm fixed-price delivery order is for the supply of the pharmaceutical product Trulicity 1.5 mg/0.5 ml pen 0.5 ml. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $8,787.76 firm fixed-price delivery order is for the pharmaceutical product Trulicity 1.5 mg/0.5 ml pen, 0.5 ml. This award is part of a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. The IDC serves as the primary...
This federal contract award, valued at $4,407.98, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a delivery order for the pharmaceutical product Trulicity 1.5 mg/0.5 mL pen, 0.5 mL. This award is part of a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. and the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. The IDC serves as the...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB23FP6Z7
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $5,175.16 firm fixed-price delivery order is for the pharmaceutical product Trulicity 4.5 mg/0.5 ml pen with a completion date of September 13, 2023. This award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 between the DLA Troop Support Medical and Cencora, Inc., which serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies to support military and veteran healthcare programs globally. The contract award does not have a set-aside designation, indicating full and open competition. This delivery order is one of many that Amerisourcebergen Drug Corp receives under the IDC to fulfill the DLA's pharmaceutical needs for military treatment facilities and other federal medical institutions.

Generated 2/27/25, 11:57 AM